<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4. Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs</caption>
<col align="left" span="1" valign="top" width="25%"></col>
<col align="left" span="1" valign="top" width="25%"></col>
<col align="left" span="1" valign="top" width="25%"></col>
<col align="left" span="1" valign="top" width="25%"></col>
<tbody>
<tr>
<th colspan="1">Atorvastatin</th>
<th colspan="3">Co-administered drug and dosing regimen</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Drug/Dose (mg)</th>
<th colspan="1">Change  in AUC</th>
<th colspan="1">Change in Cmax</th>
</tr>
<tr>
<td>80 mg QD for 15 days </td>
<td>Antipyrine, 600 mg SD</td>
<td>↑ 3%</td>
<td>↓ 11%</td>
</tr>
<tr>
<td>80 mg QD for 14 days</td>
<td>
<sup>#</sup>Digoxin 0.25 mg QD, 20 days</td>
<td>↑ 15%</td>
<td>↑ 20 %</td>
</tr>
<tr>
<td>40 mg QD for 22 days </td>
<td>Oral contraceptive QD,  2 months<br/> - norethindrone 1mg<br/>- ethinyl estradiol 35mcg</td>
<td>
<br/> ↑ 28%<br/> ↑ 19%</td>
<td>
<br/> ↑ 23%<br/>↑ 30%</td>
</tr>
<tr>
<td>10 mg, SD</td>
<td>Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</td>
<td>No change</td>
<td>No change</td>
</tr>
<tr>
<td>10 mg QD for 4 days</td>
<td>Fosamprenavir 1400 mg BID, 14 days</td>
<td>↓ 27%</td>
<td>↓ 18%</td>
</tr>
<tr>
<td>10 mg QD for 4 days</td>
<td>Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</td>
<td>No change</td>
<td>No change</td>
</tr>
</tbody>
</table>